Ritholtz Wealth Management Pfizer Inc Transaction History

Ritholtz Wealth Management

$3.29 Billion
Q1 2025

A detailed history of Ritholtz Wealth Management transactions in Pfizer Inc stock. As of the latest transaction made, Ritholtz Wealth Management holds 51,799 shares of PFE stock, worth $1.21 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

51,799

Previous 33,490 54.67%

Holding current value

$1.21 Million

Previous $888,000 47.75%

% of portfolio

0.04%

Previous 0.03%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 16, 2025	BUY	$25.01 - $27.13 $457,908 - $496,723	18,309 Added 54.67%	51,799 $1.31 Million
Q4 2024 Jan 14, 2025	SELL	$24.8 - $30.19 $540,069 - $657,447	-21,777 Reduced 39.4%	33,490 $888,000
Q3 2024 Oct 10, 2024	BUY	$27.7 - $31.39 $319,076 - $361,581	11,519 Added 26.33%	55,267 $1.6 Million
Q2 2024 Jul 31, 2024	BUY	$25.26 - $29.6 $76,108 - $89,184	3,013 Added 7.4%	43,748 $1.22 Million
Q1 2024 Apr 24, 2024	BUY	$25.89 - $29.73 $203,754 - $233,975	7,870 Added 23.95%	40,735 $1.13 Million
Q4 2023 Jan 18, 2024	BUY	$26.13 - $33.94 $120,407 - $156,395	4,608 Added 16.31%	32,865 $946,000
Q3 2023 Oct 13, 2023	SELL	$32.09 - $37.51 $519,697 - $607,474	-16,195 Reduced 36.43%	28,257 $937,000
Q2 2023 Jul 14, 2023	SELL	$36.12 - $41.79 $216,069 - $249,987	-5,982 Reduced 11.86%	44,452 $1.63 Million
Q1 2023 Apr 19, 2023	SELL	$39.39 - $51.28 $695,391 - $905,297	-17,654 Reduced 25.93%	50,434 $2.06 Million
Q4 2022 Jan 18, 2023	SELL	$41.75 - $54.5 $1.35 Million - $1.76 Million	-32,353 Reduced 32.21%	68,088 $0
Q3 2022 Oct 18, 2022	BUY	$43.76 - $53.42 $1.3 Million - $1.58 Million	29,634 Added 41.85%	100,441 $4.4 Million
Q2 2022 Jul 15, 2022	BUY	$46.53 - $55.17 $593,257 - $703,417	12,750 Added 21.96%	70,807 $3.71 Million
Q1 2022 Apr 14, 2022	BUY	$45.75 - $56.69 $171,105 - $212,020	3,740 Added 6.89%	58,057 $3.01 Million
Q4 2021 Jan 18, 2022	BUY	$41.32 - $61.25 $329,113 - $487,856	7,965 Added 17.18%	54,317 $3.21 Million
Q3 2021 Oct 14, 2021	BUY	$39.25 - $50.42 $99,577 - $127,915	2,537 Added 5.79%	46,352 $1.99 Million
Q2 2021 Jul 20, 2021	BUY	$35.91 - $40.68 $129,886 - $147,139	3,617 Added 9.0%	43,815 $1.72 Million
Q1 2021 May 12, 2021	BUY	$33.49 - $37.77 $52,277 - $58,958	1,561 Added 4.04%	40,198 $1.46 Million
Q4 2020 Jan 19, 2021	BUY	$33.47 - $42.56 $365,760 - $465,095	10,928 Added 39.44%	38,637 $1.42 Million
Q3 2020 Oct 23, 2020	BUY	$31.75 - $37.25 $101,663 - $119,274	3,202 Added 13.07%	27,709 $1.02 Million
Q2 2020 Jul 15, 2020	BUY	$30.12 - $36.54 $270,176 - $327,763	8,970 Added 57.73%	24,507 $801,000
Q1 2020 Apr 09, 2020	BUY	$27.03 - $38.62 $132,203 - $188,890	4,891 Added 45.94%	15,537 $507,000
Q4 2019 Jan 17, 2020	SELL	$32.92 - $37.36 $51,355 - $58,281	-1,560 Reduced 12.78%	10,646 $417,000
Q3 2019 Oct 17, 2019	BUY	$32.49 - $42.13 $47,760 - $61,931	1,470 Added 13.69%	12,206 $439,000
Q2 2019 Jul 15, 2019	SELL	$36.98 - $41.52 $41,232 - $46,294	-1,115 Reduced 9.41%	10,736 $465,000
Q1 2019 Apr 12, 2019	BUY	$37.5 - $41.2 $24,525 - $26,944	654 Added 5.84%	11,851 $503,000
Q4 2018 Jan 18, 2019	BUY	$38.47 - $43.86 $24,890 - $28,377	647 Added 6.13%	11,197 $489,000
Q3 2018 Oct 12, 2018	BUY	$34.47 - $41.81 $36,365 - $44,109	1,055 Added 11.11%	10,550 $465,000
Q2 2018 Jul 12, 2018	BUY	$32.98 - $35.16 $67,773 - $72,253	2,055 Added 27.62%	9,495 $344,000
Q1 2018 Apr 17, 2018	SELL	$31.91 - $37.02 $47,450 - $55,048	-1,487 Reduced 16.66%	7,440 $264,000
Q4 2017 Jan 23, 2018	BUY	$33.26 - $35.29 $26,308 - $27,914	791 Added 9.72%	8,927 $323,000
Q3 2017 Oct 17, 2017	BUY	$31.0 - $34.15 $252,216 - $277,844	8,136	8,136 $290,000

Others Institutions Holding PFE

# of Institutions

3,369

Shares Held

3.61B

Call Options Held

102M

Put Options Held

130M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $131B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ritholtz Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Ritholtz Wealth Management with notifications on news.

Account

Ritholtz Wealth Management Pfizer Inc Transaction History